pulmonary drug delivery

BL Therapeutics is a pre-clinical stage biotechnology company advancing delivery of drugs and biologics to the lung. Its BLTx liquid delivery platform delivers antibiotics and other therapeutics directly to the lungs, expanding impaired lungs while supporting oxygen exchange to facilitate homogeneous distribution. Studies demonstrate the platform can deliver pharmaceuticals, proteins and nucleic acids directly to the lung, with potential for differentiated efficacy and dosing in treating bacterial and viral pneumonia, asthma, lung cancer and other lung d

Read more

liquid drug delivery platformpre-clinical biotechnology research